KNSA
KINIKSA PHARMA (KNSA)
NASDAQ
$95.50-$0.27 (-0.28%)
Price as of Nov 12, 2026 9:55 AM EST
  • $4.0B
    Market Cap
  • 135.98%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 71
Valuation
KNSA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 75
Valuation
KNSA
vs History
vs S&P 500
3-Month Momentum
0.94%
12-Month Momentum
93.57%
3-Month Risk Adjusted Momentum
9.00%
12-Month Risk Adjusted Momentum
193.77%

True Yield

N/A
Valuation
KNSA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 73
Valuation
KNSA
vs History
vs S&P 500
Ohlson's O-Score
10